We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Doesn’t matter what we think though does it? If the market is ‘undervaluing’ COVID stocks based on the fact that there is uncertainty around how long these revenues will be sustained then that’s something that investors gave to deal with.
You can see that with NCYT. Look at their mcap given the huge revenues they are pulling in.
Tests falling off cliff in Q1 2021.
To tell who needs a vaccine you have to test. So there goes tests not being needed.
Poll showed that only 20% of people willing to take vaccine at present.
UK 'moonshot' testing tenders are for a 2 year period and I am sure other countries will be the same.
JohnHenry, I believe all Covid stocks are being undervalued at present but when NCYT are months ahead at £400m and GDR are an automated solution aimed at SA, India and US but valued at £50m then I know which is the best bet for higher % gains. This was mentioned to you and you just carried on saying how great NCYT is when all you did was back up my point that GDR can be as good in time.
All IMHO
ihavenoclue ive been trying to highlight how undervaluation of NCYT, well with yesterdays blockbuster massively so. Market hasnt cottoned on yet.
Market main concerned is vaccines hitting the market Q1 2021 and testing falling off a cliff. which i dont believe will happen
JohnHenry,
You seeing the light is a little late after the ream of posts slamming GDR and ramping NCYT.
You have a REALLY thick skin. Should be an MP. Or are you one already?
Grimshady with NCYT @ nearly 600p over £400M MKT cap yesterday and GDR @ 90p £50M MKT cap i felt GDR offered good value.
These will be a little like London buses. You wait for ages for one, then 5 come at the same time. We should have all approvals within next couple of weeks
@Gloria I believe the RNS states 1m indicative subject to approvals. It didn't state what approvals they required for this
#gell, if there is any justice then if course it should. The market has been waiting for approvals, the price dropped when none came, so the start of the upward trend must now be due. I think back up to the £120-150p range ahead of the two big ones, India and US.
People buy houses that are yet to be built...
" this approval will now provide an acceleration of commercial sales activity in the area."
1 million sales were pledged in a previous RNS (or was that for the whole of africa?!)
1 million sales this week?
I was referring to the bloke who's spent the last week telling us this company is a waste of time then claiming (without mentioning the fact)that he's bought in here,Tanker
:)
So will this move the sp?
Grim you just said what I was about to say
@oneknows
how do you know i am bi-polar?
Game changer finally. This will be £3plus any time during this next covid wave
Golden tickets
"Ive harped on about NCYT this past week trying to highlight NCYT as an investment above GDR.
Well today kinds rubber stamps that opinion.
No more from me here. GLA"
yesterday
@John your full of **** mate
Another bipolar fantasy trading odd bod......
Well done holders!! It's been a rough ride...
Time to hit previous highs!!
bloody hell
was not expecting that :)
they been rather quiet about Africa.
well now lets see what happens now :)
steady flow of approvals over the next two weeks?
maybe some in north Africa culminating in FDA WHO and India as first sales start to come in from S.A followed by U.S DoD order :) and news on POC ummm fun times.
If there had been sales it is odd not to report it now that these sales can be finalised.
This is the first of the long awaited RNS's building up... next few weeks = more approvals.. more sales... then the POC kit will be here.. A pretty good time to be in GDR id say.
Catch everyone later when we are big blue!
Excellent news, just wish it had been 6 months ago.
Top sliced NCYT added here yesterday, imho GDR is good value in the 90-100p area.
".....this approval will now provide an acceleration of commercial sales activity in the area."
An 'acceleration' in sales suggests to me there already have been some, but now with approval granted, sales can be accelerated
How can you forward sell without approval? Would you pre buy a car without an engine?